Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT05827081 |
| Title | Phase IIIb Study of Ribociclib + ET in Early Breast Cancer (Adjuvant WIDER) |
| Acronym | Adjuvant WIDER |
| Recruitment | Suspended |
| Gender | both |
| Phase | Phase III |
| Variant Requirements | No |
| Sponsors | Novartis Pharmaceuticals |
| Indications | |
| Therapies | |
| Age Groups: | adult | senior |
| Covered Countries | AUS |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| Novartis Investigative Site | Gateshead | New South Wales | 2290 | Australia | Details |